Latin America Generic Injectables Market 2021-2026: Share, Trends, Industry Analysis & Growth
According to the latest report by IMARC Group, titled “ Latin America Generic Injectables Market Report : Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026, ” the market is expected to continue its robust growth in the forecast period (2021-2026). Generic injectables are pharmaceutical drugs with the same active ingredients, strength, dosage, and administration route as of branded injectables. Some of their standard products include Prevnar 13, Eliquis, Ibrance, Lyrica, Xeljanz, etc. Generic injectables facilitate the quick onset of action, precise and adjustable dosing, and predictable bioavailability. Moreover, these injectables cost lesser than their branded counterparts, which aids in managing overhead costs related to pharma products. As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the...